Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

Launched by THE SECOND AFFILIATED HOSPITAL OF HAINAN MEDICAL UNIVERSITY · Jul 29, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new type of treatment for tumors using a special machine called the MR-Linac, which combines MRI technology with a linear accelerator to deliver precise radiation therapy. The goal is to see how well this method works in shrinking tumors and to understand any side effects patients may experience. The researchers will also look at how this treatment affects patients' quality of life.

To participate in this trial, you need to be between 18 and 75 years old and have a life expectancy of more than six months. You should also be able to tolerate the treatment without serious health issues. However, if you have conditions that make MRI unsafe for you, such as certain implants or severe health problems, you won't be eligible. If you join the trial, you will receive the MR-Linac treatment and be monitored for how well it works and any side effects you may experience. This is an exciting opportunity to contribute to research that could improve cancer treatment in the future!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients are undergoing or have undergone imaging or treatment at the MR linac;
• • Age 18-75 years, male or female;
• • ECOG score 0-2, life expectancy \> 6 months;
• • Patients provide written informed consent.
• Exclusion Criteria:
• • Contraindications to MRI, such as claustrophobia and metallic or electronic implants incompatible with MRI;
• • The presence of severe comorbidities that, in the opinion of the investigator, · preclude the toleration or completion of radiotherapy;
• • Acute inflammatory disease requiring systemic therapy;
• • The presence of active infectious disease;
• • Pregnant women, nursing mothers, and patients planning to have children during the study period.